Реблозил
(Луспатерсепт)
(25 mg)
(1 фл)
(Концентрат)
Reblozyl (luspatercept) 25 mg, original
Article:
In Stock
Summary
Luspatercept is an erythroid maturation agent used to treat anemia secondary to beta thalassemia, myelodysplastic syndromes, and neoplasms.
-
Commercial name:Реблозил
-
Сhemical name:Луспатерсепт
-
Dosage:25 mg
-
Quantity:1 фл
-
Release form:Концентрат
-
Производитель:BRISTOL MYERS
No reviews yet